Comparison of Lantus and Neutral Protamine Hagedorn (NPH) Insulin in the Dawn Phenomenon

Clinical trial NCT00694122 · COMPLETED

Trial details

NCT number: NCT00694122
Sponsor: Massachusetts General Hospital
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 1 Diabetes Dawn Phenomenon

Start date: 2005-06-01
Primary completion: 2010-11-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.